Microvascular covid-19 lung vessels obstructive thromboinflammatory syndrome (Microclots): An atypical acute respiratory distress syndrome working hypothesis

Critical Care and Resuscitation

Volumn 22, Issue 2, 2020, Pages 95-97

  Ciceri, Fabio ^a,b   Beretta, Luigi ^a,b   Scandroglio, Anna Mara ^a,b   Colombo, Sergio ^a,b   Landoni, Giovanni ^a,b   Ruggeri, Annalisa ^a   Peccatori, Jacopo ^a   D’angelo, Armando ^a   De Cobelli, Francesco ^a,b   Rovere Querini, Patrizia ^a,b   Tresoldi, Moreno ^a   Dagna, Lorenzo ^a,b   Zangrillo, Alberto ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85112503671     PISSN: 14412772     EISSN: 26529335     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. World Health Organization. Clinical management of severe acute respiratory infection when COVID-19 is suspected. Interim guidance. Version 1.2, 13 March 2020. https://www. who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. (viewed Apr 2020).
2. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506.
3. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; doi: 10.1056/NEJMoa2002032. [Epub ahead of print].
4. Herold T, Jurinovic V, Arnreich C, et al. Level of IL-6 predicts respiratory failure in hospitalized symptomatic COVID-19 patients. BMJ 2020; doi: 10.1101/2020.04.01.20047381; [Preprint, 10 April 2020].
5. Hamming I, Timens W, Bulthuis MLC, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 2004; 203: 631-7.
6. Yang D, Han Z, Oppenheim JJ. Alarmins and immunity. Immunol Rev 2017; 280: 41-56
7. Giani M, Seminati D, Lucchini A, et al. Exuberant plasmocytosis in bronchoalveolar lavage specimen of the first patient requiring extracorporeal membrane oxygenation for SARS-CoV-2 in Europe. J Thorac Oncol 2020; 10.1016/j.jtho.2020.03.008. [Epub ahead of print]
8. Monteleone G, Sarzi-Puttini P C, Ardizzone S. Preventing COVID-19-induced pneumonia with anticytokine therapy. Lancet Rheumatol 2020; doi: 10.1016/S2665-9913(20)30092-8. [Epub ahead of print]
9. Mastellos DC, Ricklin D, Lambris JD. Clinical promise of next-generation complement therapeutics. Nat Rev Drug Discov 2019; 18: 707-29.
10. Thompson BT, Chambers RC, Liu KD. Acute respiratory distress syndrome. N Engl J Med 2017; 377: 562-72.
11. Gattinoni L, Coppola S, Cressoni M, et al. COVID-19 does not lead to a “typical” acute respiratory distress syndrome. Am J Respir Crit Care Med 2020; doi: 10.1164/rccm.202003-0817LE. [Epub ahead of print]
12. Tan CW, Low JGH, Wong WH, et al. Critically ill COVID-19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability. Am J Hematol 2020; doi 10.1002/ajh.25822. [Epub ahead of print]
13. Zangrillo A, Beretta L, Silvani P, et al. Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency. Crit Care Resusc 2020. [Epub ahead of print]